Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.

Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials. J Thromb Haemost. 2013 Jul; 11(7):1287-94.

View in: PubMed

subject areas

Administration, Oral
Administration, Oral
Anticoagulants
Anticoagulants
Blood Coagulation
Blood Coagulation
Blood Coagulation Tests
Blood Coagulation Tests
Clinical Protocols
Clinical Protocols
Double-Blind Method
Double-Blind Method
Drug Administration Schedule
Drug Administration Schedule
Drug Monitoring
Drug Monitoring
Drug Therapy, Combination
Drug Therapy, Combination
Factor Xa
Factor Xa
Factor Xa Inhibitors
Factor Xa Inhibitors
Hemorrhage
Hemorrhage
Heparin, Low-Molecular-Weight
Heparin, Low-Molecular-Weight
Humans
Humans
Predictive Value of Tests
Predictive Value of Tests
Pyridines
Pyridines
Research Design
Research Design
Secondary Prevention
Secondary Prevention
Thiazoles
Thiazoles
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism
Warfarin
Warfarin

authors with profiles

Gary E Raskob